State Street Corp Shattuck Labs, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, State Street Corp holds 766,410 shares of STTK stock, worth $881,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

766,410

Previous 710,831 7.82%

Holding current value

$881,371

Previous $2.74 Million 2.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.0 - $4.85 $166,737 - $269,558	55,579 Added 7.82%	766,410 $2.67 Million
Q2 2024 Aug 14, 2024	BUY	$3.56 - $11.18 $1.98 Million - $6.2 Million	554,913 Added 355.9%	710,831 $2.74 Million
Q1 2024 May 15, 2024	BUY	$7.37 - $10.09 $170,247 - $233,079	23,100 Added 17.39%	155,918 $1.39 Million
Q4 2023 Feb 14, 2024	BUY	$1.37 - $7.24 $55,485 - $293,220	40,500 Added 43.87%	132,818 $946,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $3.26 $10,388 - $17,278	5,300 Added 6.09%	92,318 $212,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $987,292 - $1.68 Million	-365,664 Reduced 80.78%	87,018 $353,000
Q1 2022 May 16, 2022	BUY	$4.22 - $8.89 $21,863 - $46,059	5,181 Added 1.16%	452,682 $1.93 Million
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $204,351 - $515,279	24,444 Added 5.78%	447,501 $3.81 Million
Q3 2021 Nov 15, 2021	SELL	$17.57 - $28.95 $8.11 Million - $13.4 Million	-461,857 Reduced 52.19%	423,057 $8.62 Million
Q2 2021 Aug 16, 2021	BUY	$24.14 - $37.68 $2.96 Million - $4.62 Million	122,689 Added 16.1%	884,914 $25.7 Million
Q1 2021 May 17, 2021	BUY	$27.92 - $52.5 $15.7 Million - $29.6 Million	563,392 Added 283.35%	762,225 $22.3 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $3.78 Million - $11.5 Million	198,833 New	198,833 $10.4 Million

Others Institutions Holding STTK

# of Institutions

Shares Held

28.8M

Call Options Held

300

Put Options Held

1.2K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $48.7M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Shattuck Labs, Inc. Transaction History